ImmunoCellular Therapeutics (IMUC) Ramps on New Buy Rating
Tweet Send to a FriendGet Alerts IMUC Hot Sheet
Price: $2.55 -0.39%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade IMUC Now!
Shares of ImmunoCellular Therapeutics (NYSE: IMUC) are on the move after Maxim Group initiated coverage on with a Buy and aggressive $18 price target.
For an analyst ratings summary and ratings history on ImmunoCellular Therapeutics click here. For more ratings news on ImmunoCellular Therapeutics click here.
Shares of ImmunoCellular Therapeutics last traded at $3.39, up 17 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on ImmunoCellular Therapeutics click here. For more ratings news on ImmunoCellular Therapeutics click here.
Shares of ImmunoCellular Therapeutics last traded at $3.39, up 17 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Maxim Group Starts Canadian Solar (CSIQ) at Buy
- Tesla (TSLA) Pushes Back Into Positive Territory on DOE Loan Repayment
- Topeka Capital Starts NVIDIA (NVDA) at Hold
Create E-mail Alert Related Categories
Hot New Coverage, Momentum Movers, New CoverageRelated Entities
Maxim Group
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
